What Is a High CRP? Causes, Levels, and Treatment

A high CRP level signals inflammation, but what counts as high depends on context. Learn what raises CRP, when it’s a concern, and how to bring it down.

A high C-reactive protein level depends on context: for the standard CRP test used during acute illness, anything above roughly 10 mg/L signals significant inflammation, while levels above 100 mg/L usually point to a serious infection. For the high-sensitivity version of the test (hs-CRP), which detects much smaller changes, levels above 3 mg/L are considered elevated and flag increased cardiovascular risk. The distinction between these two tests, and the very different scales they operate on, is the source of most confusion when people try to interpret their results.

Two Tests, Two Scales

CRP is a protein made primarily by your liver whenever your body detects infection, tissue damage, or chronic inflammation. It can surge up to a thousand-fold during a severe infection, making it one of the most dramatic responders in blood chemistry. In healthy people, though, it normally sits at a baseline of around 1 mg/L or lower.

The standard CRP test is designed to detect the kind of dramatic spikes you see during acute illness. Its lower detection limit is around 0.3 mg/L, which means it cannot pick up the small, subtle elevations that matter for cardiovascular risk assessment. That’s where the high-sensitivity CRP test comes in. It measures the same protein using a more precise assay, allowing it to distinguish between, say, 0.5 and 2.5 mg/L. Those tiny differences turn out to be clinically meaningful for predicting heart attacks and strokes.

What the Numbers Mean

For the hs-CRP test, the widely used cardiovascular risk categories break down like this:

  • Below 1 mg/L: lower cardiovascular risk
  • 1 to 3 mg/L: moderate risk
  • Above 3 mg/L: higher risk, and this is generally where doctors start paying close attention

These thresholds were established for heart disease screening in otherwise healthy adults. An hs-CRP reading above 3 mg/L does not necessarily mean you have cardiovascular disease; it means the odds of a future event are statistically higher compared to someone with a lower level.

For the standard CRP test, the numbers are much larger. During acute illness, CRP can easily reach 100, 200, or even 300 mg/L. In one study of patients with extremely high CRP (above 500 mg/L), bacterial infections accounted for the vast majority of cases, and the mortality rate was high, particularly among patients who also had active cancers. These are levels you’d see in someone hospitalized with pneumonia, a severe abdominal infection, or sepsis, not something that shows up on a routine screening test.

Acute Causes of High CRP

The most common reason for a sharply elevated CRP is a bacterial infection. CRP rises within hours of the inflammatory trigger and can double every eight hours or so during a serious infection. Bacterial infections tend to push CRP much higher than viral ones. In one study comparing hospitalized patients, those with bacterial infections had a median CRP of 133 mg/L on admission, while those with viral infections averaged around 23 mg/L. The speed of the rise also matters: bacterial infections tend to produce a CRP velocity roughly four times faster than viral infections.

Beyond infection, trauma, surgery, burns, and autoimmune flares all cause CRP spikes. A major operation can push CRP above 100 mg/L for several days even without any infection. Autoimmune conditions like rheumatoid arthritis and lupus produce recurring spikes that reflect disease flares.

Chronic Causes and the Role of Body Fat

Mildly elevated CRP in the range of 3 to 10 mg/L, when no obvious infection or injury is present, often reflects low-grade chronic inflammation. The most common driver is excess body fat. Fat tissue actively produces inflammatory signaling molecules, which push the liver to keep making CRP at a slightly elevated baseline. A large population study found that obese women were roughly six times more likely to have elevated CRP compared to normal-weight women, and obese men were about twice as likely.

Smoking is another contributor, though its effect on CRP varies by sex and other factors. In a study of late adolescents, smoking raised hs-CRP levels in girls who were not on oral contraceptives, but the effect was not significant in boys. Oral contraceptive use itself was the strongest factor associated with higher hs-CRP in nonsmoking girls. This is worth knowing if you’re a young woman trying to interpret a mildly elevated result: hormonal contraception alone can account for a noticeable bump in hs-CRP.

Other chronic conditions that keep CRP mildly elevated include type 2 diabetes, periodontal disease, obstructive sleep apnea, and chronic kidney disease. In many cases these overlap with obesity, making it hard to tease apart which factor is driving the elevation.

Why Elevated CRP Matters for Your Heart

CRP is not just a passive bystander that reflects inflammation happening elsewhere. There is growing evidence that it actively participates in the process of blood vessel damage. It impairs the ability of blood vessel walls to relax properly, promotes stiffness, and contributes to the buildup of arterial plaque. CRP also interacts with other inflammatory molecules to amplify the cycle of vascular injury, which is why persistently elevated levels are linked to higher rates of heart attack, stroke, and heart failure.

This dual role is one reason cardiologists take hs-CRP seriously as a risk marker. It is not just predicting events because it correlates with other risk factors; it may be contributing to those events. That said, hs-CRP is most useful as a tiebreaker. For someone whose standard risk factors (cholesterol, blood pressure, family history) put them in an intermediate zone, a high hs-CRP can help tip the decision toward more aggressive prevention.

CRP in Cancer Prognosis

Persistently elevated CRP in the absence of infection or autoimmune disease can sometimes reflect an underlying malignancy. Cancer drives chronic, low-grade inflammation, and the resulting CRP elevation tends to correlate with more advanced disease and worse outcomes. In pancreatic cancer specifically, patients with high CRP levels had roughly double the risk of dying from their cancer compared to patients with lower levels, even after accounting for tumor stage and treatment.

CRP is not used as a screening tool for cancer, nor should an elevated reading cause alarm about an undiagnosed tumor. But when someone already has a cancer diagnosis, serial CRP measurements can help doctors track the inflammatory burden and gauge prognosis.

Using CRP to Track Serious Infections

In hospitals, CRP is often measured repeatedly over days rather than taken as a single snapshot. The trajectory matters more than any individual reading. Serial measurements can show whether an antibiotic is working, whether a surgical wound is becoming infected, or whether sepsis is worsening.

A study of critically ill patients with sepsis found that those whose CRP initially rose and then gradually fell had the lowest mortality rates, while patients whose CRP stayed persistently high had the worst outcomes. In another study, CRP dropped by about 23% within two days in patients who survived sepsis, while it actually increased by about 5% in those who died. That kind of early directional information can help clinicians make faster decisions about changing antibiotics or escalating care.

CRP Versus Other Inflammation Markers

You may have heard of the erythrocyte sedimentation rate (ESR), another common blood test for inflammation. CRP is generally a better indicator. It responds more quickly to changes in your clinical status, rising and falling within hours to days rather than the sluggish multi-day lag that ESR is known for. ESR is also more prone to false positives and false negatives. In practice, some doctors still order both tests because ESR can remain elevated in certain chronic conditions where CRP has already normalized, but if you had to pick one marker for acute inflammation, CRP wins.

Procalcitonin is another marker that has become more popular in hospital settings. It tends to be more specific for bacterial infections than CRP is, and it is often used alongside CRP in emergency departments to guide antibiotic decisions. Newer combination tests that pair CRP with antiviral markers are also being evaluated to help distinguish bacterial from viral illness at the point of care, with some studies showing agreement with standard reference testing above 90%. That said, CRP alone is not reliable enough to rule a bacterial infection in or out. A systematic review found that its ability to distinguish bacterial from non-bacterial infections varied considerably across studies.

How to Lower CRP

If your CRP is elevated because of an acute infection or injury, it will come down on its own once the underlying problem resolves. You do not need to “treat” CRP in that context. Treatment is more relevant when CRP is chronically elevated as part of metabolic or cardiovascular risk.

Weight loss is the most reliably effective lifestyle intervention for lowering chronically elevated CRP. In one exercise trial among women, improvements in fitness alone did not significantly lower CRP, but changes in weight did. Another study found that exercise combined with weight loss lowered CRP significantly, though the relationship was not perfectly linear: moderate weight loss seemed to produce the most CRP benefit, and the group that lost the most weight did not see proportionally greater CRP reductions. The takeaway here is that gradual, sustainable weight loss does more for CRP than extreme crash programs.

Among medications, statins are the best-studied CRP-lowering drugs. They reduce CRP independently of their effects on LDL cholesterol, and getting CRP below 2 mg/L after statin therapy is associated with fewer future cardiovascular events. In a landmark trial, patients who achieved both low LDL and low CRP after statin therapy had the best outcomes, with event rates of about 2.4 per 100 person-years compared to 4.6 per 100 person-years in those with high levels of both markers. Other lipid-lowering agents, including bempedoic acid, ezetimibe, and omega-3 fatty acids, also reduce CRP independently of their cholesterol effects.

Colchicine, a decades-old anti-inflammatory drug traditionally used for gout, has emerged as a targeted option for patients with coronary artery disease and persistently high CRP. A meta-analysis found that colchicine lowered hs-CRP and also reduced cardiovascular events by about 22% compared to placebo. In a smaller study of patients with chronic coronary artery disease and elevated hs-CRP (median 4.4 mg/L at baseline), one month of low-dose colchicine brought CRP down by roughly 40%, and over a third of patients dropped below the 2 mg/L threshold. This is a rapidly evolving area of cardiology, and colchicine is now approved in several countries specifically for reducing cardiovascular risk.

Genetics and Why Your Baseline Is Not the Same as Everyone Else’s

One underappreciated fact about CRP is that your healthy baseline is partly genetic. Variations in the CRP gene itself influence how much protein your liver produces even when nothing is wrong. Researchers have identified specific genetic variants in the CRP gene promoter that account for roughly a twofold difference in baseline CRP between people carrying different versions. These differences persist across childhood and adulthood: one long-running Finnish study found that CRP gene variants accounted for about 5% of the total variation in average CRP levels measured at two time points decades apart.

Five percent might sound small, but it means two people with identical diets, body weights, and exercise habits can have meaningfully different CRP readings based on genetics alone. Importantly, these genetic differences in baseline CRP were not driven by age, sex, race, or smoking status. This is a practical consideration if you are tracking your own CRP over time: your trend matters more than any single number, and comparing your reading against someone else’s is less informative than you might think.

When a Single CRP Reading Can Mislead You

A one-time CRP measurement is surprisingly easy to misinterpret. A common mistake is getting an hs-CRP test for cardiovascular screening while you have a minor cold, a dental infection, or sore muscles from a weekend of heavy exercise. Even a mild viral illness can push hs-CRP above 3 mg/L temporarily, producing a result that looks worrisome but means nothing for your heart. Most guidelines recommend repeating the test at least two weeks after any acute illness and averaging two readings taken at least two weeks apart.

Oral contraceptives and hormone replacement therapy are frequently overlooked confounders. As noted earlier, hormonal contraception can be the single strongest factor driving hs-CRP elevation in young women, stronger even than smoking. If your doctor orders an hs-CRP test without asking about your medications, the result may reflect your pills more than your arteries.

Time of day, recent meals, and even your sleep the night before can cause modest fluctuations. None of these are large enough to move CRP from “normal” to “dangerously high,” but they can nudge a borderline reading one way or another. For that reason, trending over time beats any single measurement, particularly for cardiovascular risk assessment where the goal is to identify your true resting baseline rather than capture a transient bump.